🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Mexico / NCT01806129
Active, not recruiting Not applicable

Reproductive Health Program in Patients With Cancer

NCT01806129 · tracked via the Priya Life Science Mexico tracker
Phase
Not applicable
Started
2016-09-02
Last updated
2026-06-03

Condition(s) studied

Malignant Neoplasm

Investigational drug(s) / intervention(s)

Standard practice related to reproductive heathTraining modules, algorithm, referral development

Standard practice related to reproductive heath: Patients undergo usual standard practice related to reproductive health.

Training modules, algorithm, referral development: Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.

Study summary

This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.

Eligibility

Sex
FEMALE
Min age
15 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Female patients presenting with initial diagnosis of any type of cancer, including patients with ductal carcinoma in situ (DCIS) * Pre-menopausal patients within the reproductive age range of 15-55 years; pre-menopausal is defined as females meeting the following criteria: * Patients not currently on hormonal contraception with the presence of menses in the past 6 months * If no menstruation in the past 6 months, without hormonal manipulation, then confirmed follicle-stimulating hormone (FSH) \< 23mlU/mL * If age \< 47 years and on hormonal contraception, then patient will be eligible regardless of menstrual history * If age ≥ 47 years and on hormonal contraception, then FSH confirmed \< 23mIU/mL * Pregnant women are eligible to participate in this study * Patients must have the cognitive ability to participate in the study Exclusion Criteria: * Patients who have initiated chemotherapy, radiation therapy or endocrine therapy prior to registration to this study * Prior hysterectomy, bilateral oophorectomy or sterilization of any method

Primary outcome measure(s)

Trial sites (109)

FacilityCityRegionStatus
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro Arkansas
Rocky Mountain Cancer Centers-Aurora Aurora Colorado
Rocky Mountain Cancer Centers-Boulder Boulder Colorado
Cancer Center of Colorado at Sloan's Lake Denver Colorado
Rocky Mountain Cancer Centers-Sky Ridge Lone Tree Colorado
SCL Health Lutheran Medical Center Wheat Ridge Colorado
Augusta University Medical Center Augusta Georgia
John B Amos Cancer Center Columbus Georgia
Hawaii Cancer Care Inc-POB II Honolulu Hawaii
Queen's Cancer Cenrer - POB I Honolulu Hawaii
Queen's Medical Center Honolulu Hawaii
Straub Clinic and Hospital Honolulu Hawaii
University of Hawaii Cancer Center Honolulu Hawaii
Queen's Cancer Center - Kuakini Honolulu Hawaii
Kapiolani Medical Center for Women and Children Honolulu Hawaii
Tripler Army Medical Center Honolulu Hawaii
Pali Momi Medical Center ‘Aiea Hawaii
John H Stroger Jr Hospital of Cook County Chicago Illinois
Carle on Vermilion Danville Illinois
Carle Physician Group-Effingham Effingham Illinois
Carle Physician Group-Mattoon/Charleston Mattoon Illinois
Carle Cancer Center Urbana Illinois
The Carle Foundation Hospital Urbana Illinois
Medical Oncology and Hematology Associates-West Des Moines Clive Iowa
Mercy Cancer Center-West Lakes Clive Iowa
Greater Regional Medical Center Creston Iowa
Medical Oncology and Hematology Associates-Laurel Des Moines Iowa
Mercy Medical Center - Des Moines Des Moines Iowa
Mercy Medical Center-West Lakes West Des Moines Iowa
Saint Joseph Hospital East Lexington Kentucky
Saint Joseph London London Kentucky
Ochsner LSU Health Monroe Medical Center Monroe Louisiana
LSU Health Sciences Center at Shreveport Shreveport Louisiana
Sanford Joe Lueken Cancer Center Bemidji Minnesota
Mercy Hospital Coon Rapids Minnesota
Fairview Southdale Hospital Edina Minnesota
Unity Hospital Fridley Minnesota
Minnesota Oncology Hematology PA-Maplewood Maplewood Minnesota
Saint John's Hospital - Healtheast Maplewood Minnesota
Abbott-Northwestern Hospital Minneapolis Minnesota

+ 69 more sites — see the full list on the official registry below.

More ECOG-ACRIN Cancer Research Group trials in Mexico

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01806129 on ClinicalTrials.gov ↗ ← All trials in Mexico